BA
Brian Abrahams RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
94
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
50%
Neutral
50%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Sector Perform
Downgraded
| $10 |
10%
upside
| 1 | +29% |
0
%
| 29 Sep ‘25 20 days ago |
|
|
Outperform
Initiated
| $60 |
9%
upside
| 1 | +44% |
0
%
| 25 Sep ‘25 24 days ago |
|
|
Sector Perform
Maintained
| $81 |
8%
downside
| 2 | – |
–
| 24 Sep ‘25 25 days ago |
|
|
Sector Perform
Downgraded
| $1.50 |
47%
upside
| 1 | – |
–
| 16 Sep ‘25 1 month ago |
|
|
Outperform
Initiated
| $70 |
17%
upside
| 1 | +27% |
0
%
| 16 Sep ‘25 1 month ago |
|
|
Outperform
Maintained
| $149 |
6%
upside
| 2 | +9.3% |
0
%
| 5 Sep ‘25 1 month ago |
|
|
Sector Perform
Initiated
| $22 |
31%
downside
| 1 | – |
–
| 3 Sep ‘25 1 month ago |
|
|
Outperform
Reiterated
| $55 |
32%
upside
| 2 | +5.4% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
Outperform
Maintained
| $19 |
48%
upside
| 1 | +8.3% |
0
%
| 14 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $63 |
4%
downside
| 1 | +9.6% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $98 |
20%
downside
| 1 | – |
–
| 8 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $11 |
25%
downside
| 1 | – |
–
| 8 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $40 |
91%
upside
| 1 | -3.7% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $405 |
3%
downside
| 1 | – |
–
| 5 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $10 |
1%
upside
| 1 | – |
–
| 5 Aug ‘25 2 months ago |
|
|
Sector Perform
Maintained
| $695 |
20%
upside
| 1 | -9.5% |
0
%
| 4 Aug ‘25 2 months ago |
|
|
Outperform
Maintained
| $219 |
53%
upside
| 1 | +1.4% |
0
%
| 1 Aug ‘25 2 months ago |
|